{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:47:55Z","timestamp":1792608475271,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,14]]},"DOI":"10.1093\/cid\/ciy230","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T19:21:29Z","timestamp":1522178489000},"page":"1072-1078","source":"Crossref","is-referenced-by-count":48,"title":["Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings"],"prefix":"10.1093","volume":"67","author":[{"given":"Karl T","family":"Johnson","sequence":"first","affiliation":[{"name":"Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J","family":"Churchyard","sequence":"additional","affiliation":[{"name":"Aurum Health, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojoon","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"key\n\t\t\t\t20180914010324_CIT0001","volume-title":"Leading causes of death by economy income group","author":"World Health Organization","year":"2015"},{"key":"key\n\t\t\t\t20180914010324_CIT0002","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new End TB Strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180914010324_CIT0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180914010324_CIT0004","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0025-7125(16)30192-4","article-title":"Preventive therapy for tuberculosis","volume":"77","author":"Miller","year":"1993","journal-title":"Med Clinics N Am"},{"key":"key\n\t\t\t\t20180914010324_CIT0005","article-title":"Isoniazid for preventing tuberculosis in non\u2010HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180914010324_CIT0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0007","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0009","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0010","volume-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","year":"2015"},{"key":"key\n\t\t\t\t20180914010324_CIT0011","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","article-title":"Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180914010324_CIT0012","first-page":"263","article-title":"Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings","volume":"9","author":"Rowe","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","article-title":"Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007\u20132009: systematic review","volume":"15 Suppl 1","author":"Fox","year":"2010","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180914010324_CIT0014","author":"Treatment Action Group"},{"key":"key\n\t\t\t\t20180914010324_CIT0015","author":"Bureau of Labor Statistics"},{"key":"key\n\t\t\t\t20180914010324_CIT0016","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda","volume":"155","author":"Mills","year":"2011","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0018","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/00002030-200010200-00021","article-title":"Mortality associated with HIV infection in rural Rakai District, Uganda","volume":"14","author":"Sewankambo","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180914010324_CIT0019","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180914010324_CIT0020","volume-title":"2016 global tuberculosis report","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180914010324_CIT0021","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0022","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciu849","article-title":"Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB\/HIV in Rio (THRio) study","volume":"60","author":"Golub","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0023","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.1317660111","article-title":"Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings","volume":"111","author":"Houben","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180914010324_CIT0024","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180914010324_CIT0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0277-9536(94)00240-T","article-title":"An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda","volume":"40","author":"Saunderson","year":"1995","journal-title":"Soc Sci Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0026","first-page":"713","article-title":"The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia","volume":"13","author":"Sutton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0027","volume-title":"Health service delivery costs","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20180914010324_CIT0028","doi-asserted-by":"crossref","first-page":"20840","DOI":"10.7448\/IAS.19.5.20840","article-title":"Annual cost of antiretroviral therapy among three service delivery models in Uganda","volume":"19(5 Suppl 4)","author":"Vu","year":"2016","journal-title":"J Int AIDS Society"},{"key":"key\n\t\t\t\t20180914010324_CIT0029","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"Vassall","year":"2011","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0030","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180914010324_CIT0031","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0035-9203(98)91036-7","article-title":"Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi","volume":"92","author":"Harries","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180914010324_CIT0033","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0034","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S1020-49892002000800017","article-title":"Macroeconomics and health: investing in health for economic development","volume":"12","author":"Sachs","year":"2002","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"key\n\t\t\t\t20180914010324_CIT0035","doi-asserted-by":"crossref","first-page":"e1001876","DOI":"10.1371\/journal.pmed.1001876","article-title":"Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial","volume":"12","author":"Liu","year":"2015","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0036","volume-title":"Country and lending groups","author":"World Bank"},{"key":"key\n\t\t\t\t20180914010324_CIT0037","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","article-title":"Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection","volume":"179","author":"Holland","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180914010324_CIT0038","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","article-title":"Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States","volume":"17","author":"Shepardson","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0039","first-page":"A7888","article-title":"Iadhere study: cost-effectiveness of self-administered isoniazid\/rifapentine for treatment of latent tuberculosis infection in the United States","author":"Holland","year":"2016","journal-title":"Tuberc Infect Dis"},{"key":"key\n\t\t\t\t20180914010324_CIT0040","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.14.0166","article-title":"Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda","volume":"19","author":"Shete","year":"2015","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/7\/1072\/25722119\/ciy230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T08:01:15Z","timestamp":1604044875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/7\/1072\/4956926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,3,30]]},"published-print":{"date-parts":[[2018,9,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy230","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10,1]]},"published":{"date-parts":[[2018,3,30]]}}}